Back to search

Article

CD28-Selective Inhibition Prolongs Non-Human Primate Kidney Transplant Survival

2023-05-05

Abstract excerpt

Costimulation blockade using belatacept results in improved renal function after kidney transplant as well as decreased likelihood of death/graft loss and reduced cardiovascular risk; however, higher rates and grades of acute rejection have prevented its widespread clinical adoption. Treatment with belatacept blocks both positive (CD28) and negative (CTLA-4) T cell signaling. CD28-selective therapies may offer imp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22a74a25-3fac-58a9-8e19-724ca88eba43
DOI
10.1101/2023.05.03.539333
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD28-Selective Inhibition Prolongs Non-Human Primate Kidney Transplant SurvivalDOI 10.1101/2023.05.03.539333
Select a neighboring publication to make it the new centre.